RAPID COMPLEMENT INHIBITION WITH THE C5 INHIBITOR CROVALIMAB: TIMING ANALYSIS USING ANIMAL MODEL AND COMPOSER TRIAL DATA
Back
E-Poster
https://storage.unitedwebnetwork.com/files/1099/7cc33f7ebe962063eb1add33b3d603af.pdf
Abstract Title
RAPID COMPLEMENT INHIBITION WITH THE C5 INHIBITOR CROVALIMAB: TIMING ANALYSIS USING ANIMAL MODEL AND COMPOSER TRIAL DATA
First Name *
Rocio
Last Name *
Soldati
Co-author 1
Cristian Brocchieri cristian.brocchieri@roche.com F. Hoffmann-La Roche Ltd. Hematology and Nephrology Rare Diseases Basel
Co-author 2
Leigh Beveridge beveridl@gene.com Genentech, Inc. Product Development Hematology San Francisco, CA
Co-author 3
Muriel Buri muriel.buri@roche.com F. Hoffmann-La Roche Ltd. Product Development (PD) Data Sciences (PDD) Basel
Co-author 4
Niels Janssen niels.janssen@roche.com F. Hoffmann-La Roche Ltd. Pharmaceutical Sciences, pRED Basel
Co-author 5
Patty Leon leon.patty@gene.com Genentech, Ltd PDH Rare Blood Disorders City: San Francisco, CA
Co-author 6
Yoshinori Tsuboi yoshinori.tsuboi@businesspartner.roche.com Chugai Pharmaceutical Co. Research Division Tokyo
Co-author 7
Simon Buatois simon.buatois@roche.com F. Hoffmann-La Roche Ltd. Pharmaceutical Sciences Basel
Co-author 8
Co-author 9
Co-author 10
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
E-Poster Format Requirements
PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but
must be saved and submitted as PDF file
.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos